KP
Katharine Peterson sold $155 of ACRV stock
Katharine Peterson, Chief Accounting Officer of Acrivon Therapeutics, Inc. (ACRV), sold 107 shares of ACRV stock worth $155, per an SEC Form 4 filed Nov 19, 2026.
It was an open-market sale.
The trade happened on Nov 17, 2026, 2 days before it was made public.
- Traded
- Nov 17, 2026
- Disclosed
- Nov 19, 2026
- Filing delay
- 2 days
- Role
- Chief Accounting Officer
- Source
- SEC Form 4